At the recent SupplySide West tradeshow, InterHealth Nutraceuticals Inc. (Benicia, CA) showcased its new weight management ingredient LOWAT, which clinical science shows may encourage weight loss over nine pounds in eight weeks.
At the recent SupplySide West tradeshow, InterHealth Nutraceuticals Inc. (Benicia, CA) showcased its new weight management ingredient LOWAT, which clinical science shows may encourage weight loss over nine pounds in eight weeks.
The patent-pending Ayurvedic ingredient, derived from Piper betle and Dolichos biflorus, was also the subject of a presentation at the 51st American College of Nutrition Meeting in New York City, held earlier this month.
In a randomized, double-blind, placebo-controlled study, 50 patients were assigned to 900 mg LOWAT or placebo for eight weeks. LOWAT was reported to significantly increase weight loss more than twice as effectively as placebo with weight loss of over nine pounds observed at eight weeks.
“We also measured two hormones – the fat-burning hormone, adiponectin and the hunger-inducing hormone, ghrelin,” said Archana Chatterjee, MD, PhD, researcher at the Creighton University School of Medicine, who presented the study. “Adiponectin levels were significantly increased by 15% compared to placebo and ghrelin levels were significantly decreased by 17%,” said Dr. Chatterjee. “The increase in adiponectin is particularly compelling as this observation suggests a possible reduction in fat stores since adiponectin is inversely correlated with body fat percentage.”
The study is pending publication in a peer-reviewed journal. Extensive safety research has been conducted already on the ingredient, according to the company.
For more information, visit InterHealth Nutraceuticals Inc.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.